APRIL PRICE: Open Payments
NPI 1740246420 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 73 payments from 25 companies in 2025. Trend: 2023 $142 · 2024 $604 · 2025 $1,554
Food & beverage: $1,554
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $226 |
| UCB, Inc. | 7 | $220 |
| Biogen, Inc. | 9 | $204 |
| Lundbeck LLC | 3 | $79 |
| PFIZER INC. | 4 | $75 |
| InSightec,Inc | 2 | $69 |
| EMD Serono, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| Neurelis, Inc. | 3 | $59 |
| Grifols USA, LLC | 2 | $58 |
Products named: Rystiggo, QULIPTA, VUMERITY, UBRELVY, SKYCLARYS, Exablate, Fintepla, INGREZZA.
Industry payments across MD — which companies pay providers there.
